Discover 2,409 paid clinical trials in Naperville, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,409
Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers
for
Breast Cancer, HER2-positive Breast Cancer,
Location: Chicago IL, Madison WI, Rochester NY, Hershey PA
Sponsor: Ruth O'Regan
Sex: All
Age: 18+
Code: NCT04886531
Phase 2, Recruiting
LUNG-05: Investigating Chemotherapy Effectiveness for Non-Small Cell Lung Cancer (NSCLC) Metastatic Patients
for
NSCLC
Location: Chicago IL
Sponsor: University of Illinois at Chicago
Sex: All
Age: 18+
Code: NCT06576635
Recruiting
Implementation of Population Cancer Genetic Services in Federally Qualified Health Centers (FQHC)
for
Hereditary Cancer Syndrome
Location: Chicago IL
Sponsor: University of Illinois at Chicago
Sex: All
Age: 25+
Code: NCT05664867
Recruiting
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
for
Prostate Cancer
Location: Chicago IL, Milwaukee WI, Iowa City IA, St Louis MO,
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18 - 70+
Code: NCT06855277
Phase 3, Recruiting
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
for
CRC (Colorectal Cancer)
Location: Chicago IL, Evanston IL, Springfield IL,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT07284849
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
for
Metastatic Head-and-neck Squamous-cell Carcinoma,
Location: Chicago IL, St Louis MO, Columbus OH, Westwood KS,
Sponsor: AVEO Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06064877
Phase 3, Recruiting
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors